These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Limited prescribing freedom by federal cost regulation?]. Lasek R Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):633-5. PubMed ID: 9527458 [TBL] [Abstract][Full Text] [Related]
44. Legislative forum ... Comprehensive HIV Prevention Act of 1993. Berry K J Healthc Qual; 1993; 15(4):38. PubMed ID: 10128804 [No Abstract] [Full Text] [Related]
45. Compendium of Measures to Prevent Disease Associated with Animals in Public Settings, 2017. ; Daly RF; House J; Stanek D; Stobierski MG J Am Vet Med Assoc; 2017 Dec; 251(11):1268-1292. PubMed ID: 29154705 [No Abstract] [Full Text] [Related]
46. The "dangerous" infected patient. An approach to characterizing the risks posed by persons with communicable infectious diseases. Goodman RA J Leg Med; 2009; 30(1):13-26. PubMed ID: 19241271 [No Abstract] [Full Text] [Related]
47. ["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology]. Ptok M; Schönweiler R; Nawka T; HNO; 2004 Jan; 52(1):45-9. PubMed ID: 14740114 [No Abstract] [Full Text] [Related]
48. [MSD executive calls for more transparency and expertise. 9 out of 10 innovations fail due to a too brief value assessment (interview by Wolfgang van den Bergh, Dirk Einecke and Cornelius Heyer)]. Quodt H MMW Fortschr Med; 2011 Jan; 153(4):10. PubMed ID: 22165606 [No Abstract] [Full Text] [Related]
50. [Robert Koch's contribution to the development of disinfection and current main points of disinfection in research and practice]. Weuffen W Z Gesamte Hyg; 1982 Mar; 28(3):167-71. PubMed ID: 7048757 [No Abstract] [Full Text] [Related]
53. When global health is local health. Infectious diseases travel easily. Katz JR; Hirsch AM Am J Nurs; 2003 Dec; 103(12):75-9. PubMed ID: 14702570 [No Abstract] [Full Text] [Related]
54. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?]. Schwarz S; Frölich L; Striebel JP; Hennerici MG Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346 [No Abstract] [Full Text] [Related]
55. [Off-label use of drugs--the legal framework]. Koyuncu A Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512 [No Abstract] [Full Text] [Related]